Opioid Use in Pelvic Fractures: The Impact of Opioid Prescribing Laws in Pennsylvania.

Authors

Nicole Ann E Villa
Kristina Shum
Allison Atkinson
Adrian Ong, Department of Surgery, Tower Health Systems, Reading Hospital, West Reading, PAFollow
Alison Muller, Department of Surgery, Tower Health Systems, Reading Hospital, West Reading, PAFollow
Eduardo Espiridion, Department of Psychiatry, Tower Health Systems, Reading Hospital, West Reading, PAFollow

Document Type

Article

Publication Date

7-2024

Abstract

Pennsylvania's Prescription Drug Monitoring Program (PDMP) was established in 2016, but its impact on opioid use for pelvic fractures is understudied. We compared opioid use in 277 pelvic fracture cases between two periods: 2015-2017 (T1) and 2018-2020 (T2). Outcomes included daily inpatient morphine milligram equivalents (MME), long-term opioid use (LOU) 60-90 days post-discharge, and intermediate-term opioid use (IOU) 30-60 days post-discharge. T1 and T2 had comparable baseline characteristics. T2 was associated with a decrease in average daily inpatient MME (58.6 vs 78.5,

Publication Title

The American surgeon

Volume

90

Issue

7

First Page

1937

Last Page

1939

Recommended Citation

Villa, N., Shum, K., Atkinson, A., Ong, A., Muller, A., & Espiridion, E. (2024). Opioid Use in Pelvic Fractures: The Impact of Opioid Prescribing Laws in Pennsylvania.. The American surgeon, 90 (7), 1937-1939. https://doi.org/https://doi.org/10.1177/00031348241241644